Madrigal Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Madrigal Pharmaceuticals

MDGL 445.03

+7.9%

Nov 4 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: tuck	11/12/2018 1:27:15 PM
	Read Replies (1) of 138

Madrigal is presenting at the AASLD meeting today. There was some nervousness ahead of the 36 week data, but that seems to have come out pretty well, and the stock is up some while the market sells off hard. A biotweeter has a couple of screen shots of their presentation: Liver Enzymes Safety and Biomarkers The main news here is some F3 patients responded, and some were betting against that. Change in Fibrosis Score on Liver Biopsy Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next